Breaking News on Global Pharmaceutical Technology & Manufacturing

Merck & Co to buy Avecia Biologics

21-Dec-2009 - US drug major Merck & Co will buy into the UK's contract biologics manufacturing sector with the acquisition of Tees Valley-based Avecia Biologics.

Hospira to buy injectables biz from India’s Orchid

21-Dec-2009 - Hospira will pay India’s Orchid Chemicals and Pharmaceuticals approximately $400m (€278m) for its generic injectables business.

Recipharm moves for Cobra to boost biologics capacity

17-Dec-2009 - Swedish CDMO Recipharm will buy privately-owned group Cobra Biomanufacturing to build its presence in the expanding biologics sector.

News in brief

Taro cites Sun’s “conduct at Caraco” ahead of AGM

15-Dec-2009 - Taro Pharmaceutical Industries has warned shareholders about “Sun’s conduct at Caraco” in its latest effort to block the Indian firm’s takeover bid.

EU clears Amcor takeover of Alcan

15-Dec-2009 - Amcor’s takeover of Alcan has been cleared by the European Commission after the Australian company agreed to sell off two pharmaceutical and food packaging plants in Spain.

Amcor prepares for life after Alcan takeover

11-Dec-2009 - Amcor has unveiled its proposed management shake up in preparation for the $2.025bn takeover of Alcan – three days before the European Commission is due to deliver its verdict on...

Watson completes Arrow deal, adding generic Lipitor to US portfolio

07-Dec-2009 - Watson Pharmaceuticals gained US rights to market a generic version of Lipitor (atorvastatin) in 2011 with the acquisition of non-branded drugmaker Arrow Group late last week.

News in brief

Sterling to buy Canadian drug plant

03-Dec-2009 - Australia’s Sterling Products plans to buy a 4,310 sqm pharmaceutical manufacturing plant from a Canadian drugmaker that has fallen victim to the global economic crisis.

News in brief

Merck & Co to close NJ warehouse with loss of 80 jobs

26-Nov-2009 - US drugmaker Merck & Co is to close a New Jersey warehouse owned by recent acquisition Schering-Plough, cutting 80 jobs.

Millipore buys Indian JV

24-Nov-2009 - Millipore has acquired the remaining 60 per cent of its Indian joint venture (JV) to drive growth in the country which it views, along with the other BRICS nations, as...

Emergent buys Baltimore production plant

17-Nov-2009 - US biotech Emergent BioSolutions has bought a manufacturing facility from Maryland’s MdBio Foundation is a bid to expand its production infrastructure.

Six Pfizer-Wyeth R&D sites to close post merger

10-Nov-2009 - Pfizer will close six R&D facilities in the US and the UK, reducing its global capacity by over a third following completion of its acquisition of Wyeth.

News in brief

New Jersey R&D sites vital, says Merck CEO

05-Nov-2009 - US R&D facilities in Rahway and Kenilworth, New Jersey will remain operational as they are vital to the to the newly formed Merck Schering-Plough group, according to CEO Richard Clark....

Lonza cuts 2009 guidance 14% and plans workforce cuts

02-Nov-2009 - Lonza cuts 2009 earning guidance and may reduce its workforce under “Project Bond” cost cutting plan after a Q3 characterized by an “accumulation of unexpected events”

IMS Health looking at buyout bids

22-Oct-2009 - IMS Health has confirmed it is “exploring strategic alternatives” after speculation this week suggested that the market analysis group had received a number of takeover bids.

Lonza withdraws Patheon bid, but still keen on CMOs

20-Oct-2009 - Swiss healthcare services giant Lonza has withdrawn its offer for Canadian CMO Patheon, citing value considerations, rejection of the bid by JLL and the availability of alternatives.

H Lundbeck eschews outsourcing and buys Elaiapharm

20-Oct-2009 - CNS focused drugmaker H Lundbeck says its acquisition of French CMO Elaiapharm represents a cheaper option than third-party manufacturing.

News in brief

Lilly sells Tippecanoe API site to Evonik

15-Oct-2009 - US drugmaker Eli Lilly will sell its Tippecanoe laboratories API manufacturing unit to Germany’s Evonik Industries.

Lonza builds in India in Simbiosys deal; updates on Patheon takeover

15-Oct-2009 - Lonza says that to the Indian market was a key motivation for its acquisition of Simbiosys Biowares India preclinical cell and molecular biology assets.

CPhI 2009 show preview

08-Oct-2009 - We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.

MannKind’s shares tumble; deal unlikely in 2009

07-Oct-2009 - MannKind’s share price tumbled by 31 per cent yesterday, just days after it published encouraging safety data for Afresa, because it revealed a partnership deal is unlikely to occur in 2009.

French govt unlikey to relinquish grip on health spending, says BMI

06-Oct-2009 - Despite the government’s “aggressive” promotion of generic drugs, pharmaceutical spending in France will continue to grow, according to new analysis by Business Monitor International (BMI).

Hospira buys facility & filgrastim rights to boost biogenerics

06-Oct-2009 - Hospira has acquired the worldwide rights to filgrastim and a Croatian biologics plant from Pliva, increasing its presence in the biogenerics field, and told in-PharmaTechnologist that further expansions are possible.

Sun says Taro suit is “baseless litigation”

01-Oct-2009 - Sun Pharmaceuticals says the new lawsuit filed against it by Taro Pharmaceuticals is “another unfortunate attempt by the Taro directors to divert Taro's limited resources to assisting the Levitt family...

News in brief

J&J buys 18% of Crucell

29-Sep-2009 - US health care major J&J has paid €302m for an 18 per cent stake in Dutch biotechnology Crucell and announced plans for a collaborative drug development programme.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...